The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2017 | Inherited and acquired genetic factors involved in the development of CLL
John Gribben, MD, DSc, FRCP, FRCPath, FMed ,Sci from Barts Cancer Institute, London, UK, chairs a discussion following the ‘Inherited and Acquired Genetic Factors Involved in the Development of CLL’ session, at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017, held in New York, NY. Prof. Gribben is joined by chronic lymphocytic leukemia (CLL) colleagues Olivier A. Bernard, PhD from INSERM Gustave Roussy Institute, Villejuif, France and Stephan Stilgenbauer, MD from Ulm University, Ulm, Germany to discuss the highlights from this session. The session focused on the biology and science underpinning CLL disease development, which gives rise to questions regarding how recent advances will impact the clinical treatment of CLL? In addition, the session included data on the etiology and genetic factors associated with CLL.
